Newsletter | February 20, 2019

02.20.19 -- Top 5 Strategies To Execute And Document GCP/GVP Vendor Oversight

 
Featured Editorial
Top 5 Strategies To Execute And Document GCP/GVP Vendor Oversight
 
By Penelope Przekop, MSQA, RQAP-GCP

Over the last 10 years the face of clinical R&D and pharmacovigilance (PV) outsourcing has dramatically changed. What was a common industry scenario by 2010 — a full-scale operational pharma company utilizing both international and U.S.-based CROs to execute clinical investigator site monitoring and data management — has evolved into a new common scenario in 2019.

Digital Platforms For Patient Engagement In Clinical Trials: Trends And Outlook
By Mathini Ilancheran, principal analyst, R&D, Beroe Inc.

Pharmaceutical companies have three targeted users: physicians, pharmacists, and patients. Various digital platforms are used to create a good customer experience for educating these end users. The core focus is on patients driving patient care, education, and adherence.

Industry Insights
Disrupting Clinical Operations With CRO Strategic Partnerships
Article | By Craig Morgan, goBalto

With most sponsors utilizing an outsourcing model of some kind, the biggest opportunity might still lie ahead. As the industry adapts to be more budget-minded and efficient, the quest for innovation remains. So, what does meaningful innovation look like for the clinical trial industry?

The Challenge With Early-Phase Oncology Trials
Podcast | Worldwide Clinical Trials

Less than 10 percent of oncology patients actually participate in clinical trials. How can a trial be easy or effective if patient participation is low? Get the tips you need to run better early-phase oncology trials now.

Protein Therapeutics By Immunoaffinity LC-MS: Latest Trends And Recommendations
Webinar | Q2 Solutions

Learn about the application of immunoaffinity LC-MS to regulated bioanalysis of biotherapeutics.

How Linear Clinical Research Accelerated Trials Timelines And Improved Global Collaboration With eSource
Webinar | Medrio

Explore the ways Medrio eSource has enabled Phase 1 clinical research unit to improve global collaboration and accelerate trial timelines.

Navigating The Complexities Of NASH Development: Valuable Insights From A Key Opinion Leader
Webinar | Medpace

In this webinar, medical and operations experts from Medpace facilitate a Q&A session with Dr. Stephen A. Harrison, an experienced key opinion leader (KOL) in NASH. The presenters participate in an in-depth discussion on selected topics associated with NASH development as well as strategies and opportunities for researchers.

Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With Clinical Leader:
   LinkedIn    Twitter